-
Uncategorized3 weeks ago
Nourish raises $100M for virtual nutrition care
***embargoed for 8am ET tomorrow tues 5/19*** Nourish, a telehealth platform that arranges virtual appointments with nutritionists, just raised a new round that bumped its valuation...
-
Uncategorized3 weeks agoSTAT+: Eli Lilly tops prominent rankings on pharma R&D performance
Here’s one more sign of Eli Lilly’s dominance in the drug industry: It took both top spots in a prominent ranking of pharmaceutical innovators and investors....
-
Uncategorized3 weeks ago
BioMarin suffers another blow to rare disease portfolio in Phase 3 flop
BioMarin’s investigational therapy failed to elicit clinical improvements in patients with ENPP1 deficiency, while also missing key secondary endpoints of rickets severity and growth.
-
Uncategorized3 weeks agoThe latest on Ebola: A travel ban and an old vaccine
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. STAT’s Breakthrough Summit West is today!...
-
Uncategorized3 weeks ago
FDA’s own report shows no child deaths definitively caused by COVID vaccination
Despite having no definitive data, Sen. Ron Johnson (R-WI) in a letter to health secretary Robert F. Kennedy, Jr. suggested there was a conscious effort by...
-
Uncategorized3 weeks ago
Relay’s PI3Kα inhibitor clears efficacy bar in Phase 2 vascular anomalies study
Relay Therapeutics’ first data readout for zovegalisib in a rare genetic disease beat Wall Street expectations, expanding the PI3Kα inhibitor’s R&D prospects beyond breast cancer. The...
-
Uncategorized3 weeks ago
BioMarin’s rare disease therapy shows no clinical benefit in Phase 3 test
BioMarin's rare disease therapy shows no clinical benefit in Phase 3 test
-
Uncategorized3 weeks agoOpinion: I’m a heart transplant recipient. I’m haunted by ‘ghost approval’ for medication I need to survive
I’m a heart transplant recipient. The medications I take aren’t optional — they’re what keep my body from rejecting my heart. So when my transplant team...
-
Uncategorized3 weeks agoOpinion: Britain embraces a Massachusetts experiment on tobacco regulation — just as the state might roll it back
The United Kingdom just adopted a tobacco-free generation law. Retailers can still sell tobacco to existing customers, but they will never be permitted to sell it...
-
Uncategorized3 weeks ago
Biotech can’t continue to innovate under strain of Big Pharma market pressures
Biotech is increasingly financed, governed and regulated as though it were a mature pharmaceutical industry rather than a discovery system built around scientific uncertainty. Structural changes...
FDA imposes import alert on Indian plant after inspectors flag GMP failings
